2015
DOI: 10.1093/annonc/mdv471.84
|View full text |Cite
|
Sign up to set email alerts
|

Establishment of a terminal prognosis prediction model by applying time series analysis to real-world data

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2017
2017
2018
2018

Publication Types

Select...
1
1

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Attempts to identify older patients at risk of death in emergency departments [9] to improve prognostic accuracy are reported in the literature for 30-day mortality [24] or 1-year prediction [25]. For short-term mortality (3–4 months), our model results were better than those of risk stratification tools in France [26], Holland [8], and Japan [27]. Others have also found old age, multimorbidity, increasing age, frailty or cancer as common predictors of 3-month mortality [26, 2830], but no validation has been reported for some (Table 3).…”
Section: Discussionmentioning
confidence: 98%
“…Attempts to identify older patients at risk of death in emergency departments [9] to improve prognostic accuracy are reported in the literature for 30-day mortality [24] or 1-year prediction [25]. For short-term mortality (3–4 months), our model results were better than those of risk stratification tools in France [26], Holland [8], and Japan [27]. Others have also found old age, multimorbidity, increasing age, frailty or cancer as common predictors of 3-month mortality [26, 2830], but no validation has been reported for some (Table 3).…”
Section: Discussionmentioning
confidence: 98%
“…Because patients' condition during treatment course can change from the baseline, development of an adaptable prognosis prediction model, which could be applied at any time point after the initiation of chemotherapy, is warranted in practice. Thus, we are developing adaptable prognostic models for patients with cancer receiving chemotherapy [87]. In this case-crossover study, we recruited 2693 patients, and 3,471,521 laboratory data at 115,738 time points, representing 40 laboratory items that were monitored for 1 year before the death event, were applied in developing prognostic models.…”
Section: Future Planmentioning
confidence: 99%